Diagnosis

Lichen planus

Chronic inflammation of the skin or mucous membranes causing lichenificating lesions.

Etiology

Cause [aue][rd9]

Pathophysiology [aue][rd9]

Complications [iom][aue]

Epidemiology

Incidence per 100.000 [iom][35c][f1t][uru]

Epidemiology chart for Incidence

Prevalence per 100.000 [iom][35c][f1t][uru]

Epidemiology chart for Prevalence

Symptoms & findings

Symptoms

Onycholysis, Pruritus, Xeroderma

Clinical findings

None listed.

Anamneses

None listed.

Localized findings

Rash
Radiates
CaputCollumThoraxAbdomenGenitalArmBackLower body
Distribution
AsymmetricFlexuralLocalizedSingle
Lesion type
ErythemaLichenificationPapuleUlcer
Lesion surface
Lichenoid
Color
RedViolet
Associated symptom
Itch

Approach

Treatment

The condition is self-limited and generally lasts 6–24 months [35c][aue]

  1. Symptomatic treatment:

    • Avoid: spicy/acidic food, alcohol, tobacco

    • Antihistamine (pruritus)

    • Steroid cream twice daily for 2 to 4 weeks

    • Intralesional steroid injections (triamcinolone 5 to 10 mg/mL)

  2. First-line therapy:

    • Oral corticosteroids (prednisone 30 to 60 mg) tapered over 2 to 6 weeks

  3. Second-line therapy: [aue]

    • Metronidazole (500 mg twice daily for 3 to 8 weeks)

    • Sulfasalazine (500 mg twice daily increased until 2.5 grams daily, for 3 to 6 weeks)

    • Isotretinoin (10 mg twice daily for 2 months)

    • Acitretin (30 mg daily for 8 weeks)

    • PUVA, UVB

    • Topical calcineurin inhibitors

    • Methotrexate (15 mg per week for adults, 0.25 mg/kg per week for children)

  4. Third line therapy: Trimethoprim-sulfamethoxazole, griseofulvin, terbinafine, antimalarials, tetracyclines, ciclosporin, mycophenolate mofetil, azathioprine, etanercept, adalimumab, or low-molecular-weight heparin [aue]

Differential diagnoses

Candidiasis, Cutaneous T-cell lymphoma, Drug side effects, Eczema, Graft-versus-host disease, Lichenoid keratosis, Lichen sclerosus, Paget's disease, Parapsoriasis, Pityriasis lichenoides, Pityriasis rosea, Pityriasis rubra pilaris, Pityriasis versicolor, Psoriasis, Squamous cell carcinoma, Syphilis, Systemic lupus erythematosus, Tinea corporis


References

[1] Arnold DL, Krishnamurthy K. Lichen Planus. [Updated 2024 Oct 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK526126/

[2] [Clinical Dermatology 4.th Edition by Weller, Hunter, Savin and Dahl]

[3] Halonen P, Jakobsson M, Heikinheimo O, Gissler M, Pukkala E. Incidence of Lichen Planus and Subsequent Mortality in Finnish Women. Acta Derm Venereol. 2020 Oct 28;100(17):adv00303.

[4] Pannell RS, Fleming DM, Cross KW. The incidence of molluscum contagiosum, scabies and lichen planus. Epidemiol Infect. 2005 Dec;133(6):985-91.

[5] Nagao T, Ikeda N, Fukano H, Hashimoto S, Shimozato K, Warnakulasuriya S. Incidence rates for oral leukoplakia and lichen planus in a Japanese population. J Oral Pathol Med. 2005 Oct;34(9):532-9.

[6] Schruf E, Biermann MH, Jacob J, Häckl D, Reinhardt M, Hertl M, Wohlrab J. Lichen planus in Germany - epidemiology, treatment, and comorbidity. A retrospective claims data analysis. J Dtsch Dermatol Ges. 2022 Aug;20(8):1101-1110.

[7] Carbone M, Arduino PG, Carrozzo M, Gandolfo S, Argiolas MR, Bertolusso G, Conrotto D, Pentenero M, Broccoletti R. Course of oral lichen planus: a retrospective study of 808 northern Italian patients. Oral Dis. 2009 Apr;15(3):235-43.

Scroll to top